NCT00355407View on ClinicalTrials.gov

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

NACompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Hematologic Malignancies

Interventions

DRUG

Darbepoetin alfa

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER